• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

guidance

Pfizer
Pharma

Pfizer's COVID franchise keeps guidance level after strong Q1

Buoyed by notable sales beats from Eliquis, Prevnar and Ibrance, Pfizer’s revenue rose 2% year over year on an operational basis to $14.5 billion.
Fraiser Kansteiner May 5, 2026 11:17am
Eli Lilly Lilly

Lilly sees big sales increase in 2026 despite pricing pressures

Feb 4, 2026 2:55pm
Quitting quit resigning resignation exit head for exit heads for exit

Organon hunts for new CEO after probe exposes sales misconduct

Oct 27, 2025 10:00am
sales sales increase

Teva forecasts $5B-plus in innovative drug sales by 2030

May 30, 2025 7:20am
Boerner

BMS accentuates the positive after Cobenfy trial flop

Apr 24, 2025 11:31am
JNJ

J&J lifts 2025 sales guidance despite looming tariff threat

Apr 15, 2025 11:55am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings